Beta-adrenoceptor-blocking drugs, growth hormone and acromegaly.

Action of several -adrenoceptor blocking drugs in the pregnant sheep and foetus.

1. The effect of several beta-adrenoceptor blocking drugs on the pregnant ewe and foetus were studied. Bunolol, butidrine, oxprenolol, propranolol and USVP65-24 all crossed the ovine placenta and produced a beta-adrenoceptor blockade in the ovine foetus. AH3474, AY21011 and sotalol did not cross the ovine placenta as assessed by the absence of a beta-blockade in the foetus when these compounds ...

Pharmacological properties of beta-adrenoceptor blocking drugs

Pharmacodynamic and pharmacokinetic studies on prizidilol and nipradilol (K-351), antihypertensive drugs with combined vasodilator and beta-adrenoceptor blocking actions, in rabbits.

Effects of prizidilol and nipradilol (K-351), beta-adrenoceptor antagonists with vasodilator action, on blood pressure and heart rate were studied in normotensive conscious rabbits after i.v. administration. In addition, we investigated relationships between plasma drug concentrations and beta-adrenoceptor blocking activity as estimated by the inhibition of isoproterenol-induced tachycardia and...

Thiazides, beta blockers and lipoproteins.

Some of the more important recent studies on the effect of thiazides and beta-adrenoceptor blocking agents is conflicting, possibly because of differences in patient compliance and in lipoprotein methodology and quality assurance between studies. It is likely that in the short-term, thiazide diuretics produce an increase in plasma triglyceride and cholesterol and in LDL-cholesterol. No consiste...

Therapeutic uses of beta-adrenoceptor blocking drugs in the central nervous system in man.

Although beta-adrenoceptor antagonists were first developed for their potential therapeutic uses in cardiac disease, it was soon recognized during clinical trials that they had effects on the central nervous system, some ofthem unwanted, but others ofpossible therapeutic value. This paper reviews some recent developments in this area of beta-adrenoceptor clinical pharmacology, earlier studies h...